Sermorelin & Ipamorelin Blend (10mg)

$81.00

Sermorelin & Ipamorelin Blend (10mg) is offered by Biotech Peptides for laboratory and analytical research. This blend combines Sermorelin, a 29-residue GHRH analogue, with Ipamorelin, a 5-residue ghrelin mimetic, for studies of receptor signaling and neuroendocrine pathways. 1078

  • Product: Sermorelin & Ipamorelin Blend

  • Listed quantity: 10 mg

  • Components: Sermorelin and Ipamorelin

  • Intended use: Laboratory and analytical research only

Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.

For research use only. Not for human consumption.

SKU: Sermorelin-Ipamorelin-10mg Category:
Description

Sermorelin & Ipamorelin Blend (10mg) for Laboratory Research

Sermorelin & Ipamorelin Blend (10mg) is offered by Biotech Peptides for laboratories investigating growth hormone regulatory signaling, receptor convergence, and neuroendocrine feedback pathways. The blend combines Sermorelin, a synthetic 29-residue GHRH analogue, with Ipamorelin, a synthetic 5-residue ghrelin mimetic. 1078

For laboratories looking to buy Sermorelin & Ipamorelin Blend, this listing identifies a 10 mg quantity. Confirm the supplied material’s component ratio, salt state, and analytical characteristics against the requirements of the intended work.

Explore our research peptides for sale to review other laboratory-use listings.

Blend Product Information

Property Listing information
Product name Sermorelin & Ipamorelin Blend
Listed quantity 10 mg
Components Sermorelin and Ipamorelin
Intended application Laboratory and analytical research
Documentation inquiries Include the product name and batch or lot number, where available

The 10 mg designation describes the total quantity stated for this listing. It does not independently establish the amount of each component, net peptide content, or confirm that a particular quantity-assay method has been performed.

Reference Molecular Characteristics

The following characteristics describe the reference structures of the two components. They are not analytical confirmation of an individual commercial blend batch.

Component Reference molecular formula Approximate molecular weight PubChem identifier
Sermorelin C₁₄₉H₂₄₆N₄₄O₄₂S 3357.9 g/mol 16129620
Ipamorelin C₃₈H₄₉N₉O₅ 711.9 g/mol 9831659

The molecular formulas and molecular weights are documented in the PubChem Sermorelin Acetate reference record and the PubChem Ipamorelin reference record. Confirm the supplied salt state and any counterions against manufacturer specifications before using reference values in analytical calculations. 1085

Sermorelin is a synthetic 29-amino-acid peptide corresponding to the amino-terminal segment of endogenous human growth hormone-releasing hormone. It is also called GHRH(1-29)-NH2 or GRF(1-29) amide. The sequence is documented in the Sermorelin research summary and in the Sermorelin research summary. 1079

Ipamorelin is a synthetic 5-residue ghrelin mimetic with growth hormone-releasing activity. The sequence is documented in the PubChem Ipamorelin reference record.

GHRH and GHS-R1a Receptor Research

Sermorelin binds selectively to the GHRH receptor, a class B G-protein-coupled receptor expressed predominantly on somatotroph cells in the anterior pituitary. Receptor engagement activates adenylyl cyclase, increasing intracellular cyclic AMP concentrations. 1076

Ipamorelin is a selective growth hormone secretagogue receptor agonist that activates the GHS-R1a receptor. Receptor engagement activates phospholipase C, increasing intracellular calcium concentrations. 1076

A review of growth hormone secretagogues describes Sermorelin as a GHRH analog that impacts the hypothalamic-pituitary-somatotropic axis, unlike other GHS which function via the ghrelin/GHS-R pathway. 1076

Read the review of growth hormone secretagogues for the molecular mechanisms and evidence limitations.

Growth Hormone Pulsatility Research

A study evaluating Sermorelin reported that the peptide may increase mean nocturnal GH release by approximately 100%, GH peak amplitude by 33.3%, and 12-hour GH levels by approximately 82.5%, suggesting an immediate response. The investigators also reported that Sermorelin did not change the frequency of GH pulses or levels of IGF-I, IGFBP-3, or GHBP. 1076

A separate study of Ipamorelin reported that the peptide may enhance the peak synthesis of growth hormone by pituitary cells by more than 60-fold. The investigators reported that Ipamorelin may elevate growth hormone levels during a peak to around 80 mIU/L, equivalent to about 26.6 ng/mL. 1076

These findings apply to specific experimental protocols and do not establish that a commercial blend increases growth hormone in humans. 1076

Research Limitations

Published Sermorelin and Ipamorelin research examines receptor signaling, cell-based assays, and animal models. It does not establish that a commercial blend increases growth hormone, improves body composition, supports recovery, or treats any condition. 1076

Published research also does not verify the identity, purity, component ratio, quantity, or biological activity of the commercial blend supplied with this listing.

Documentation and Batch Verification

Before selecting Sermorelin & Ipamorelin Blend (10mg), review the information associated with the exact material being supplied. Depending on your protocol, relevant documentation may include:

  • Product name and batch or lot identifier.

  • Manufacturer specifications and chemical form.

  • Component ratio and total blend quantity.

  • Salt state and counterion information, where applicable.

  • Identity-testing methods and reported results.

  • Purity-testing methods and supporting analytical data.

  • Quantity or peptide-content measurements, where required.

  • Product-specific storage and handling instructions.

Match identifiers across the label, specifications, and analytical reports. Obtain clarification if the documentation uses inconsistent component ratios, sequences, or molecular values.

For inquiries, provide “Sermorelin & Ipamorelin Blend (10mg),” the batch number where available, and the specific information your laboratory requires.

Storage and Handling

Follow the product-specific instructions supplied with the material and your laboratory’s applicable procedures.

Do not transfer storage temperatures, shelf-life claims, or preparation instructions from another supplier’s formulation or a differently modified peptide. Obtain clarification if documented instructions are unavailable or unclear.

Frequently Asked Questions About Sermorelin & Ipamorelin Blend (10mg)

What is Sermorelin & Ipamorelin Blend?

It is a research blend combining Sermorelin, a synthetic 29-residue GHRH analogue, with Ipamorelin, a synthetic 5-residue ghrelin mimetic. 1078

What does the 10mg designation mean?

It is the total quantity stated for this listing. It does not describe the amount of each component, a concentration, or independently establish net peptide content.

Does this blend increase growth hormone?

Published research examines receptor signaling and growth hormone release in specific cell-based and animal models. It does not establish that a commercial blend increases growth hormone in humans. 1076

Does published research verify this product?

No. Publications describe the materials and conditions used by the investigators. Assess a commercial blend using relevant manufacturer specifications and analytical evidence.

Where can I find delivery information?

Review our shipping information for current order-processing and delivery terms.

Research Use Only

Sermorelin & Ipamorelin Blend (10mg) is sold for laboratory and analytical research only. Not for human or animal consumption, personal administration, medical treatment, diagnosis, or veterinary application.

Review our Research-Use-Only Policy before ordering.

Additional information
BrandBiotech Peptides
Shipping & Delivery